Accéder au contenu
Merck

Diet-induced obesity in mice reduces placental efficiency and inhibits placental mTOR signaling.

Physiological reports (2014-04-20)
Susanne Lager, Anne-Maj Samulesson, Paul D Taylor, Lucilla Poston, Theresa L Powell, Thomas Jansson
RÉSUMÉ

As in humans, obesity during pregnancy in mice results in elevated maternal insulin levels and metabolic programming of offspring. mTOR signaling regulates amino acid transport and may function as a placental nutrient sensor. Because obesity is a condition with increased nutrient availability, we hypothesized that diet-induced obesity activates placental mTOR signaling. To test this hypothesis, female C57BL/6J mice were fed an obesogenic diet or standard chow prior to and throughout pregnancy. Fetuses and placentas were collected at gestational day 18. Using Western blot analysis, placental mTOR activity was determined along with energy, inflammatory, and insulin signaling pathways (upstream modulators of mTOR). At gestational day 18, fetal and placental weights did not differ, however, in obese dams, the fetal/placental weight ratio was lower (P <0.01). In placentas from obese dams, mTOR signaling was inhibited, as determined by decreased Rheb and S6K1 expression, and lower rpS6 phosphorylation (P <0.05). In contrast, energy, inflammatory, and insulin signaling pathways were unaffected. Contrary to our hypothesis, diet-induced obesity in pregnant mice was associated with inhibition of placental mTOR signaling. However, this finding is consistent with the lower fetal/placental weight ratio, indicating reduced placental efficiency.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Anticorps anti-IRS1, Upstate®, from rabbit
Sigma-Aldrich
Anti-phospho-Insulin Receptor Substrate-1 (pTyr612) antibody produced in rabbit, affinity isolated antibody, buffered aqueous glycerol solution